Eric dEsparbes - Feb 15, 2024 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIOR)

Role
Chief Financial Officer
Signature
/s/ Clarke Neumann, Attorney-in-Fact for Eric d'Esparbes
Stock symbol
BIOR
Transactions as of
Feb 15, 2024
Transactions value $
$0
Form type
4
Date filed
2/15/2024, 04:05 PM
Previous filing
Aug 17, 2023
Next filing
Aug 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIOR Common Stock Award $0 +325K +116.63% $0.00 604K Feb 15, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 325,000 restricted stock units, 25% of which will vest on February 15, 2025, with the remaining shares vesting in equal semi-annual installments through February 15, 2028, subject to the Reporting Person's continued service to the Issuer.